Pharma Journalist -

Enveric Biosciences a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced that it has acquired an…
Read More...

Sparta Biopharma, Inc., a privately-held company, developing osteobiologics for sports medicine announces the availability of BioEnthesis, the first-of-its-kind allograft that has both…
Read More...

NeuroRx, Inc. and TFF Pharmaceuticals, Inc. are announcing that the companies have entered into a feasibility and material transfer agreement (Feasibility Agreement). Under the…
Read More...

Novartis announced the Phase III CANOPY-2 study evaluating canakinumab (ACZ885), an inhibitor of interleukin-1beta (IL-1β), in combination with the chemotherapy agent docetaxel, did not…
Read More...

Valo Therapeutics Limited (Valo Tx), the developer of novel and adaptable immunotherapy platforms for cancer and infectious diseases, announced the completion of a successful…
Read More...

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announce the initiation of enrollment of its…
Read More...

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Maverick Therapeutics, Inc. a private biopharmaceutical company pioneering conditionally active…
Read More...

Melior Pharmaceuticals (Melior) announced that it has received clearance of its Investigational New Drug (IND) application for the clinical development of its novel, first-in-class lyn…
Read More...

Eli Lilly and Company and Biolojic Design Ltd. a biotechnology company that computationally designs functional antibodies, announced a research collaboration and license agreement that…
Read More...

Exelixis, Inc. and WuXi Biologics announced the companies have entered into an exclusive license agreement to support the continued expansion of Exelixis’ oncology biologics pipeline.…
Read More...